Aripiprazole
Schizophrenia, Tourette’s Disorder
Boxed warning
- WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS WITH ANTIDEPRESSANT DRUGS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Aripiprazole tablets are not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions ( 5.1) ]. Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in ... (see full label)
Indications
- Schizophrenia
- Tourette’s Disorder
Adult dosing
- schizophrenia: dose: 10; unit: mg; route: PO; interval: 10 to 15 mg/day; fixed: true; labelExcerpt: The recommended starting and target dose for aripiprazole tablets is 10 or 15 mg/day administered on a once-a-day schedule without regard to meals. Aripiprazole tablets have been systematically evaluated and shown to be effective in a dose range of 10 to 30 mg/day
Pediatric dosing
- schizophrenia: dose: 2; unit: mg; route: PO; interval: 2 mg/day initially, titrated to 10 mg/day; fixed: true; labelExcerpt: The starting daily dose of the tablet formulation in these patients was 2 mg, which was titrated to 5 mg after 2 days and to the target dose of 10 mg after 2 additional days.
- tourette lt50kg: dose: 2; unit: mg; route: PO; interval: 2 mg/day initially, target 5 mg/day, max 10 mg/day; fixed: true; labelExcerpt: For patients weighing less than 50 kg, dosing should be initiated at 2 mg/day with a target dose of 5 mg/day after 2 days. The dose can be increased to 10 mg/day in patients who do not achieve optimal control of tics.
- tourette ge50kg: dose: 2; unit: mg; route: PO; interval: 2 mg/day initially, target 10 mg/day, max 20 mg/day; fixed: true; labelExcerpt: For patients weighing 50 kg or more, dosing should be initiated at 2 mg/day for 2 days, and then increased to 5 mg/day for 5 days, with a target dose of 10 mg/day on Day 8. The dose can be increased up to 20 mg/day
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Known hypersensitivity to aripiprazole
Clinical pearls
- Administer once daily without regard to meals.
- Monitor for metabolic changes including weight gain, glucose levels, and lipid levels.
- Monitor for suicidal thoughts and behaviors in children, adolescents, and young adults.
- Dosage adjustments are required for known CYP2D6 poor metabolizers and patients taking strong CYP3A4/CYP2D6 inhibitors or strong CYP3A4 inducers.
Source and review
- DailyMed label (aripiprazole), Set ID 0cf6655e-d59a-4ebd-9698-195cad2adbd5, effective 2026-11-03. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties